Search for: "Anda Pharmaceuticals, Inc"
Results 241 - 260
of 607
Sort by Relevance
|
Sort by Date
4 Aug 2013, 9:53 pm
• Defendant: Sun Pharma Global FZE; Sun Pharmaceutical Industries, LTD.; Sun Pharmaceutical Industries, Inc. [read post]
30 Jul 2013, 2:01 pm
Lexis 1688, at *36) to Merrell Dow Pharmaceuticals, Inc. v. [read post]
29 Jul 2013, 12:16 pm
Mylan Pharmaceuticals Inc. et al., C.A. [read post]
15 Jul 2013, 8:50 pm
Teva Parenteral Medicines, Inc., et al., C.A. [read post]
23 Jun 2013, 8:50 pm
• Defendants: Par Pharmaceutical Inc.; Actavis Elizabeth LLC; Actavis Inc. [read post]
3 Jun 2013, 8:59 am
Roxane Laboratories, Inc., C.A. [read post]
17 May 2013, 9:09 am
Sandoz Inc., C.A. [read post]
7 May 2013, 12:27 pm
Chief Judge Gregory Sleet recently denied a generic pharmaceutical company’s request for leave to move for summary judgment before a Rule 16(b) conference in an ANDA case. [read post]
29 Apr 2013, 2:53 pm
Zydus Pharmaceuticals (USA) Inc., et al., C.A. [read post]
11 Apr 2013, 7:38 am
In re Armodafinil Patent Litigation Inc. [read post]
11 Apr 2013, 4:57 am
FTC Sues Regarding AndroGel Patent SettlementThe Federal Trade Commission has filed a complaint in federal district court challenging agreements in which Solvay Pharmaceuticals, Inc. paid generic drug makers Watson Pharmaceuticals, Inc. and Par Pharmaceutical Companies, Inc. to delay generic competition to Solvay’s branded testosterone-replacement drug AndroGel, a prescription pharmaceutical with annual sales of more than $400… [read post]
3 Apr 2013, 4:45 am
But the recent split Federal Circuit panel decision in Momenta Pharmaceuticals, Inc. v. [read post]
1 Apr 2013, 8:29 am
” Upon receiving this reissue patent, Pfizer immediately filed a lawsuit against Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Lupin Pharmaceuticals, USA, Inc.; Apotex Corp.; and Apotex, Inc. in the United States District Court for the Eastern District of Virginia for infringement of the reissue patent. [read post]
26 Mar 2013, 5:17 pm
Actavis, Inc: A Quick Look into Reverse Paymentsby George YuThe name of the game in the pharmaceutical industry is exclusivity. [read post]
13 Mar 2013, 4:05 pm
Endo Pharmaceuticals Inc. v. [read post]
10 Mar 2013, 9:59 pm
Searle LLC; Pfizer Asia Pacific PTE, LTD.; • Defendants: Lupin Pharmaceuticals, Inc.; Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Apotex Inc.; Apotex Corp. [read post]
28 Feb 2013, 7:46 am
As part of its ANDA filing, Accord alleged that the claims of the '209 patent are invalid and/or not infringed by Accord's product. [read post]
25 Feb 2013, 11:00 pm
Watson Pharmaceuticals, Inc., the Federal Circuit reversed the district court’s finding that two Orange Book-listed patents for Cephalon’s FENTORA® product were invalid, but affirmed the district court’s finding that Watson’s ANDA product would not... [read post]
20 Feb 2013, 7:37 am
Teva Pharmaceuticals USA Inc., et. al., 1-10-cv-00805 (DED February 11, 2013, Order) (Burke, M.J.). [read post]
15 Feb 2013, 9:29 am
Teva Pharmaceuticals USA, Inc., C.A. [read post]
